Xcout IntelSign inSubscribe

Nyxoah SA competitors & alternatives

NYXHMedical DevicesMont-Saint-Guibert, Belgium

The 12 closest competitors and alternatives to Nyxoah SA among medical devices companies — ranked by similarity to what Nyxoah SA actually does, not by market-cap band.

$55.5MMarket cap
163Employees
12Competitors listed

Subscribe to see Nyxoah SA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Nyxoah SA

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Nyxoah SA at a glance

Nyxoah SA is a medical devices company headquartered in Mont-Saint-Guibert, Belgium, founded in 2009. It is publicly listed (NYXH) with a market capitalisation of $55.5M. Xcout tracks 19 named people at Nyxoah SA, including Olivier Taelman (Chief Executive Officer).

Nyxoah SA leadership

  • Olivier TaelmanChief Executive Officer
  • Loic MoreauPresident of International
  • John LandryChief Financial Officer
  • Bruno OnkelinxChief Technical Officer
  • Ashlea MittelstaedtChief Strategy Officer
  • Geeta KavetiChief Compliance Officer

13 more named people on record for Nyxoah SA, with roles, board committees and tenure — see the full roster →

Nyxoah SA funding rounds on record

Every round on record:

DateRoundAmountInvestors
—$20M—
Series A$10.3M—

Some filings are not shown as funding rounds.

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Recent Nyxoah SA news

3 corporate events on record, with sources — see the full timeline →

Top 12 Nyxoah SA competitors

Ranked by semantic similarity — how close each company is to Nyxoah SA by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

LivaNovaLIVN · Medical DevicesGloucester, United Kingdom
65% matchPublic

Similar medical devices company

LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.

Market cap$4.2B
Employees3,300
LivaNova competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Nyxoah SA and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Nyxoah SAand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →